Induction of immune tolerance in mice with a novel mucosal nanoemulsion adjuvant and self-antigen

Nanomedicine

Volumn 7, Issue 6, 2012, Pages 867-876

  Wang, Su He ^a   Fan, Yongyi ^a   Makidon, Paul E ^a   Cao, Zhengyi ^a   Baker, James R ^a  

^a UNIVERSITY OF MICHIGAN HEALTH SYSTEM   (United States)

Author keywords

autoimmune; immune tolerance; nanoemulsion; thyroiditis

Indexed keywords

ANTIBODY; AUTOANTIGEN; GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 17; LIPOPOLYSACCHARIDE; SOYBEAN OIL EMULSION; THYROGLOBULIN; THYROGLOBULIN ANTIBODY; TRANSCRIPTION FACTOR FOXP3; TRANSFORMING GROWTH FACTOR BETA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBODY TITER; ARTICLE; AUTOIMMUNE THYROIDITIS; AUTOIMMUNITY; CELL MIGRATION; CELL PROLIFERATION; CERVICAL LYMPH NODE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DISEASE SEVERITY; FEMALE; HISTOPATHOLOGY; HUMORAL IMMUNE DEFICIENCY; IMMUNOLOGICAL TOLERANCE; MOUSE; NANOEMULSION; NONHUMAN; NOSE; PRIORITY JOURNAL; REGULATORY T LYMPHOCYTE; SPLEEN CELL; THYMUS;

ADJUVANTS, IMMUNOLOGIC; ADMINISTRATION, INTRANASAL; ANIMALS; AUTOANTIBODIES; EMULSIONS; FEMALE; FORKHEAD TRANSCRIPTION FACTORS; GENE EXPRESSION; IMMUNE TOLERANCE; INTERFERON-GAMMA; INTERLEUKIN-10; INTERLEUKIN-17; MICE; MICE, INBRED CBA; RNA, MESSENGER; SOYBEAN OIL; T-LYMPHOCYTES, REGULATORY; THYROGLOBULIN; THYROID GLAND; THYROIDITIS, AUTOIMMUNE; TRANSFORMING GROWTH FACTOR BETA;

EID: 84862835769     PISSN: 17435889     EISSN: 17486963     Source Type: Journal    
DOI: 10.2217/nnm.11.187     Document Type: Article

References (28)

1. Wang SH, Bretz JD, Phelps et al. A unique combination of inflammatory cytokines enhances apoptosis of thyroid follicular cells and transforms nondestructive to destructive thyroiditis in experimental autoimmune thyroiditis. J. Immunol. 168, 2470-2474 (2002).
2. Caturegli P, Hejazi M, Suzuki K et al. Hypothyroidism in transgenic mice expressing IFN-gamma in the thyroid. Proc. Natl Acad. Sci. USA 97, 1719-1724 (2000).
3. Kong YC, Morris GP, Brown NK, Yan Y, Flynn JC, David CS. Autoimmune thyroiditis, a model uniquely suited to probe regulatory T cell function. J. Autoimmun. 33, 239-246 (2009).
4. Bielinska AU, Janczak KW, Landers JJ, Markovitz DM, Montefiori DC, Baker JR. Nasal immunization with a recombinant HIV gp120 and nanoemulsion adjuvant produces Th1 polarized responses and neutralizing antibodies to primary HIV type 1 isolates. AIDS Res. Hum. Retroviruses 24, 271-281 (2008).
5. Makidon PE, Knowlton J, Groom JV et al. Induction of immune response to the 17 kDa OMPA Burkholderia cenocepacia polypeptide and protection against pulmonary infection in mice after nasal vaccination with an OMP nanoemulsion-based vaccine. Med. Microbiol. Immunol. 199, 81-89 (2010).
6. Hamouda T, Chepurnov A, Mank N et al. Efficacy, immunogenicity and stability of a novel intranasal nanoemulsion-adjuvanted influenza vaccine in a murine model. Hum. Vaccin. 6, 585-594 (2010).
7. Makidon PE, Bielinska AU, Nigavekar SS et al. Pre-clinical evaluation of a novel nanoemulsion-based hepatitis B mucosal vaccine. PLoS ONE 3(8), e2954 (2008).
8. Bielinska AU, Gerber M, Blanco LP et al. Induction of Th17 cellular immunity with a novel nanoemulsion adjuvant. Crit. Rev. Immunol. 30, 189-199 (2010).
9. Berg G. An electron microscopic study of the thyroglobulin molecule. J. Ultrastruct. Res. 42, 324-336 (1973).
10. Singh Y, Lakshmy R, Gupta R, Kranthi V. A rapid 3% polyacrylamide slab gel electrophoresis method for high through put screening of LDL phenotype. Lipids Health Dis. 7, 47 (2008).
11. Wang SH, Cao Z, Wolf JM, Van Antwerp M, Baker JR. Death ligand tumor necrosis factor-related apoptosis-inducing ligand inhibits experimental autoimmune thyroiditis. Endocrinology 146, 4721-4726 (2002).
12. Wang SH, Chen GH, Fan Y, Van Antwerp M, Baker JR. Tumor necrosis factor-related apoptosis-inducing ligand inhibits experimental autoimmune thyroiditis by the expansion of CD4+CD25+ regulatory T cells. Endocrinology 150, 2000-2007 (2009).
13. Finkelman FD, Katona IM, Mosmann TR, Coffman RL. IFN-g regulates the isotypes of Ig secreted during in vivo humoral immune responses. J. Immunol. 140, 1022-1027 (1988).
14. Kong YM, Okayasu I, Giraldo AA, Beisel KW, Sundick RS, Rose NR. Tolerance to thyroglobulin by activating suppressor mechanisms. Ann. NY Acad. Sci. 392, 191-209 (1982).
15. Kang HK, Michael MA, Berner BR, Datta SK. Very low-dose tolerance with nucleosomal peptides controls lupus and induces potent regulatory T cell subsets. J. Immunol. 174, 3247-3255.
16. Kang HK, Liu M, Datta SK. Low-dose peptide tolerance therapy of lupus generates plasmacytoid dendritic cells that cause expansion of autoantigen-specific regulatory T cells and contraction of inflammatory Th17 cells. J. Immunol. 178, 7849-7858 (2007).
17. Oluwole SF, Oluwole OO, Adeyeri AO, DePaz HA. New strategies in immune tolerance induction. Cell Biochem. Biophys. 40(3 Suppl.), 27-48 (2004).
18. Bhowmick S, Mazumdar T, Ali N. Vaccination route that induces transforming growth factor beta production fails to elicit protective immunity against Leishmania donovani infection. Infect. Immun. 77, 1514-1523 (2009).
19. Crane IJ, Forrester JV. Th1 and Th2 lymphocytes in autoimmune disease. Crit. Rev. Immunol. 25, 75-102 (2005).
20. Gangi E. Vasu C. Cheatem D. Prabhakar BS. IL-10-producing CD4+CD25+ regulatory T cells play a critical role in granulocyte-macrophage colony-stimulating factor-induced suppression of experimental autoimmune thyroiditis. J. Immunol. 174, 7006-7013 (2005).
21. Alexis NE, Lay JC, Almond M, Peden DB. Inhalation of low-dose endotoxin favors local T(H)2 response and primes airway phagocytes in vivo. J. Allergy Clin. Immunol. 114, 1325-1331 (2004).
22. Uzonna JE, Joyce KL, Scott P. Low dose Leishmania major promotes a transient T helper cell type 2 response that is down-regulated by interferon gamma-producing CD8+ T cells. J. Exp. Med. 199, 1559-1566 (2004).
23. Figueroa-Vega N, Alfonso-Pérez M, Benedicto I, Sánchez-Madrid F, González- Amaro R, Marazuela M. Increased circulating proinflammatory cytokines and Th17 lymphocytes in Hashimoto's thyroiditis. J. Clin. Endocrinol. Metab. 95, 953-962 (2010).
24. Horie I, Abiru N, Nagayama Y et al. T helper type 17 immune response plays an indispensable role for development of iodine-induced autoimmune thyroiditis in nonobese diabetic-H2h4 mice. Endocrinology. 150, 5135-5142 (2009).
25. Mauermann N, Burian J, von Garnier C et al. Interferon-gamma regulates idiopathic pneumonia syndrome, a Th17+CD4+ T-cell-mediated graft-versus-host disease. Am. J. Respir. Crit. Care Med. 178, 379-388 (2008).
26. Ge W, Jiang J, Liu W et al Regulatory T cells are critical to tolerance induction in presensitized mouse transplant recipients through targeting memory T cells. Am. J. Transplant. 10, 1760-1773 (2010).
27. Dinesh RK, Skaggs BJ, La Cava A, Hahn BH, Singh RP. CD8+ Tregs in lupus, autoimmunity, and beyond. Autoimmun. Rev. 9, 560-568 (2010).
28. Yu S, Fang Y, Sharp GC, Braley-Mullen H. Transgenic expression of TGF-b on the thyrocytes inhibits development of spontaneous autoimmune thyroiditis and increases regulatory T cells in thyroids of NOD.H-2h4 mice. J. Immunol. 184, 5352-5359 (2010).